Healthcare -
Biotechnology - NASDAQ - GB
$ 0.2575
1.68 %
$ 65.9 M
Market Cap
-0.81
P/E
ADAP - TOTAL CURRENT LIABILITIES
Total Current Liabilities ADAP - Adaptimmune Therapeutics plc
64.5 M
LAST VALUE
0.02%
2 YEAR CAGR
13.45%
5 YEAR CAGR
1.97%
10 YEAR CAGR